Holland Foundation for Sight Restoration Welcomes New Leaders
The Holland Foundation for Sight Restoration recently announced the additions of Marjan Farid, M.D., and James Mazzo to its Board of Directors. These appointments align with the Foundation's mission to transform the lives of patients facing severe ocular surface disease through innovative solutions and resources.
Expertise That Transforms Lives
Marjan Farid, M.D. is celebrated for her expertise in anterior segment surgery, establishing the first Center of Excellence at the University of California, Irvine. Her profound knowledge and dedication contribute significantly to the Foundation's goals of advancing surgical education and patient care.
James Mazzo brings over four decades of executive leadership experience in the eyecare industry. His background in building organizations based on excellence equips the Holland Foundation with strategic insight crucial for navigating the challenges in ocular health.
Commitment to Corneal Transplantation
The Holland Foundation for Sight Restoration is unique—dedicated exclusively to addressing unmet medical needs related to corneal transplantation for patients suffering from Severe Ocular Surface Disease. This condition, which can severely impair vision and quality of life, requires the collective efforts of specialists and institutions committed to advanced care.
The Impact of the Centers of Excellence
The Foundation has successfully established four Centers of Excellence in collaboration with leading health institutions, such as the Cincinnati Eye Institute and Mass Eye and Ear. These centers allow for heightened patient care through specialized treatments formulated by top experts in the field.
The Cincinnati Protocol, developed by Dr. Edward J. Holland, is pioneering in educating physicians on the complexities of corneal surgery. This initiative aims to standardize care and ensure that all patients receive the highest quality treatment possible.
Advancement Through Leadership
Stephen Lane, M.D., Executive Chairman and President of the Foundation, expressed enthusiasm regarding the new board members: "The leadership of Marjan and Jim strengthens our commitment to excellence in ophthalmic care. Their insights and experience will facilitate substantial advancements in our mission to combat blinding corneal disease."
Dr. Farid’s role as a leading ophthalmic surgeon will enhance the Foundation’s education initiatives, bringing a wealth of knowledge on treating complex cases. Similarly, Jim Mazzo’s extensive network and industry reputation will support the organization’s outreach and growth strategies.
About Marjan Farid, M.D.
Dr. Farid holds the position of Director of Cornea, Cataract, and Refractive Surgery at the UCI Health Gavin Herbert Eye Institute. Her contributions reflect a strong commitment to patient care, research, and educational outreach. Dr. Farid is known for her innovative techniques and her work with the Severe Ocular Surface Disease Program, which is instrumental in advancing surgical techniques.
About James Mazzo
James Mazzo’s impressive career highlights his capability to lead and innovate in the eyecare sector. As Executive Chair of Neurotech Pharmaceuticals and past leadership roles in major corporations, his efforts consistently set new standards in the industry. His ability to mobilize resources and insights will play a crucial role in furthering the Foundation's mission.
The Holland Foundation for Sight Restoration
This nonprofit organization endeavors to transform the lives of individuals suffering from Severe Ocular Surface Disease, including conditions like limbal stem cell deficiency. Co-founded by Robert J. Dempsey and Edward J. Holland, M.D., the Foundation stands unique in its commitment to addressing the pressing need for effective corneal transplantation.
Equipping medical professionals and standardizing care through The Cincinnati Protocol™ are the core missions of the Foundation. Their continuous efforts focus on building Centers of Excellence globally to provide comprehensive medical and surgical care.
Fundraising Campaign: Light After Darkness
The Light After Darkness fundraising campaign aims to raise $5 million over five years. This initiative is dedicated to supporting the Holland Foundation's vision of delivering comprehensive care to those affected by corneal blindness due to Severe OSD. Through this campaign, the Foundation will empower surgeons, foster advanced clinical care, and drive research innovation.
Media Contact
For further information about the Holland Foundation for Sight Restoration, please contact:
Kila Hanrahan
Executive Director
(859) 409-0009
Frequently Asked Questions
What is the primary goal of the Holland Foundation for Sight Restoration?
The primary goal of the Foundation is to transform the lives of individuals affected by Severe Ocular Surface Disease through innovative medical solutions and resources.
Who are the new board members appointed?
Marjan Farid, M.D., and James Mazzo are the newly appointed members of the board.
What are the Centers of Excellence?
These centers are specialized institutions aimed at delivering advanced care for patients suffering from Severe Ocular Surface Disease.
How does the Foundation help in education?
The Foundation provides education through The Cincinnati Protocol™, designed to enhance the skills of medical professionals treating ocular conditions.
What is the Light After Darkness campaign?
This campaign is a fundraising initiative to support the Foundation’s mission to aid patients suffering from corneal blindness.
